Investigators report increased frequencies of hematopoietic stem cell (HSC), HPC and lineage negative cells in the elderly but a decreased frequency of multi-lymphoid progenitors. Aged human HSCs further exhibited a delay in initiating division ex vivo though without changes in their division kinetics.
1254621 Y9SFTHCG items 1 apa default asc 1
The authors expressed oncogenic NrasG12D within the hematopoietic system in mice and interrogated its effects on hematopoietic stem cell survival.
1254621 G9Q77LQY items 1 apa default asc 1
Researchers used droplet digital PCR or PCR for antigen receptor rearrangement, to explore tumor-specific point mutations, copy number alterations, and chromosomal rearrangements in the plasma of cancer-affected dogs. They detected circulating tumor DNA in 21/23 of histiocytic sarcoma, 2/8of oral melanoma, and 12/13 of lymphoma cases.
6445212 IT8SCWWZ items 1 apa default asc 1
Prouteau, A., Denis, J. A., De Fornel, P., Cadieu, E., Derrien, T., Kergal, C., Botherel, N., Ulvé, R., Rault, M., Bouzidi, A., François, R., Dorso, L., Lespagnol, A., Devauchelle, P., Abadie, J., André, C., & Hédan, B. (2021). Circulating tumor DNA is detectable in canine histiocytic sarcoma, oral malignant melanoma, and multicentric lymphoma. Scientific Reports, 11(1), 877. https://doi.org/10.1038/s41598-020-80332-y Cite
Investigators showed that protein synthesis rates declined during hematopoietic stem cell (HSC) ontogeny, yet erythroid protein synthesis rates increased. A ribosomal mutation that impairs ribosome biogenesis disrupted both fetal and adult HSC self-renewal.
[Stem Cell Reports]
1254621 TTXIDN86 items 1 apa default asc 1
The authors conducted two lines of genome-editing experiments of mouse hematopoietic stem cells (HSCs) with the clustered regularly interspaced short palindromic repeat (CRISPR) and CRISPR-associated protein 9 (Cas9).
[Molecular Therapy-Methods & Clinical Development]
1254621 YWBX7A6W items 1 apa default asc 1
Investigators demonstrated using an embryonic stem cell model that transient expression of the T-box transcription factor Eomesodermin governed hemogenic competency of extra-embryonic mesoderm.
[Nature Cell Biology]
6445212 IIQWDSXG items 1 apa default asc 1
Harland, L. T. G., Simon, C. S., Senft, A. D., Costello, I., Greder, L., Imaz-Rosshandler, I., Göttgens, B., Marioni, J. C., Bikoff, E. K., Porcher, C., de Bruijn, M. F. T. R., & Robertson, E. J. (2021). The T-box transcription factor Eomesodermin governs haemogenic competence of yolk sac mesodermal progenitors. Nature Cell Biology, 23(1), 61–74. https://doi.org/10.1038/s41556-020-00611-8 Cite
Researchers developed a mice model for studying the hematopoietic syndrome in the non-uniform or partial body exposure scenarios using the localized cobalt60 gamma radiation exposure.
1254621 9PF3LFHT items 1 apa default asc 1
Scientists identified novel potential microRNAs bound up with the diagnosis and prognosis of myelodysplastic syndromes (MDS). miRNA microarray analysis was used to screen deregulated microRNAs in the bone marrow of MDS patients.
1254621 TB2LR4S8 items 1 apa default asc 1
Scientists found that Zinc finger protein 521 (Zfp521) deletion did not inhibit adult hematopoiesis under homeostatic conditions. In contrast, Zfp521-null chimeric mice showed significantly reduced pool size of hematopoietic stem cells and hematopoietic progenitor cells associated with increased apoptosis and loss of quiescence.
1254621 AIZPESPL items 1 apa default asc 1
Scientists report that UM171 potentiated the activity of a CULLIN3-E3 ubiquitin ligase complex whose target specificity was dictated by the poorly characterized Kelch/BTB domain protein KBTBD4.
[Cell Stem Cell]
1254621 7TFCS6BU items 1 apa default asc 1
The authors review several biological and clinical aspects related to leukemia-initiating cells (LICs) in acute lymphoblastic leukemia (ALL), including: 1) immunophenotypic characterization of LIC-enriched subsets in human and mouse models of ALL; 2) emerging therapeutics against regulatory signaling pathways involved in LIC progression and maintenance in T- and B-cell leukemias; 3) novel epigenetic and age-related mechanisms of LIC propagation, and 4) ongoing efforts in immunotherapy to eradicate LIC-enriched cell subsets in relapsed and refractory ALL cases.
1254621 UFEGSDYL items 1 apa default asc 1